Choroid Plexus Papillomas of the Foramen of Luschka: MR Appearance
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Intraventricular Neuroepithelial Tumors: Surgical Outcome, Technical Considerations and Review of Literature A
Aftahy et al. BMC Cancer (2020) 20:1060 https://doi.org/10.1186/s12885-020-07570-1 RESEARCH ARTICLE Open Access Intraventricular neuroepithelial tumors: surgical outcome, technical considerations and review of literature A. Kaywan Aftahy1* , Melanie Barz1, Philipp Krauss1, Friederike Liesche2, Benedikt Wiestler3, Stephanie E. Combs4,5,6, Christoph Straube4, Bernhard Meyer1 and Jens Gempt1 Abstract Background: Intraventricular neuroepithelial tumors (IVT) are rare lesions and comprise different pathological entities such as ependymomas, subependymomas and central neurocytomas. The treatment of choice is neurosurgical resection, which can be challenging due to their intraventricular location. Different surgical approaches to the ventricles are described. Here we report a large series of IVTs, its postoperative outcome at a single tertiary center and discuss suitable surgical approaches. Methods: We performed a retrospective chart review at a single tertiary neurosurgical center between 03/2009–05/ 2019. We included patients that underwent resection of an IVT emphasizing on surgical approach, extent of resection, clinical outcome and postoperative complications. Results: Forty five IVTs were resected from 03/2009 to 05/2019, 13 ependymomas, 21 subependymomas, 10 central neurocytomas and one glioependymal cyst. Median age was 52,5 years with 55.6% (25) male and 44.4% (20) female patients. Gross total resection was achieved in 93.3% (42/45). 84.6% (11/13) of ependymomas, 100% (12/21) of subependymomas, 90% (9/10) of central neurocytomas and one glioependymal cyst were completely removed. Postoperative rate of new neurological deficits was 26.6% (12/45). Postoperative new permanent cranial nerve deficits occurred in one case with 4th ventricle subependymoma and one in 4th ventricle ependymoma. -
Malignant Glioma Arising at the Site of an Excised Cerebellar Hemangioblastoma After Irradiation in a Von Hippel-Lindau Disease Patient
DOI 10.3349/ymj.2009.50.4.576 Case Report pISSN: 0513-5796, eISSN: 1976-2437 Yonsei Med J 50(4): 576-581, 2009 Malignant Glioma Arising at the Site of an Excised Cerebellar Hemangioblastoma after Irradiation in a von Hippel-Lindau Disease Patient Na-Hye Myong1 and Bong-Jin Park2 1Department of Pathology, Dankook University College of Medicine, Cheonan; 2Department of Neurosurgery, Kyunghee University Hospital, Seoul, Korea. We describe herein a malignant glioma arising at the site of the resected hemangioblastoma after irradiation in a patient with von Hippel-Lindau disease (VHL). The patient was a 25 year-old male with multiple heman- gioblastomas at the cerebellum and spinal cord, multiple pancreatic cysts and a renal cell carcinoma; he was diagnosed as having VHL disease. The largest hemangioblastoma at the right cerebellar hemisphere was completely removed, and he received high-dose irradiation postoperatively. The tumor recurred at the same site 7 years later, which was a malignant glioma with no evidence of hemangioblastoma. The malignant glioma showed molecular genetic profiles of radiation-induced tumors because of its diffuse p53 immunostaining and the loss of p16 immunoreactivity. The genetic study to find the loss of heterozygosity (LOH) of VHL gene revealed that only the cerebellar hemangioblastoma showed allelic losses for the gene. To the best of our knowledge, this report is the first to show a malignant glioma that developed in a patient with VHL disease after radiation therapy at the site of an excised hemangioblastoma. This report also suggests that radiation therapy should be performed very carefully in VHL patients with hemangioblastomas. -
Current Diagnostic and Therapeutic Strategies in Treatment of CNS Hemangioblastomas in Patients with VHL
Journal of Central Translational Medicine & Epidemiology Special Issue on von Hippel Lindau Disease Edited by: Hiroshi Kanno Professor, Department of Neurosurgery, Yokohama City University School of Medicine, Japan Review Article *Corresponding author Sven Gläsker, Department of Neurosurgery, Freiburg University Medical Center, Breisacher Str. 64, D-79106, Current Diagnostic and Freiburg, Germany, Tel: 49(0)761-270-50010; Fax: 49(0)761-270-50080; Email: Therapeutic Strategies Submitted: 11 November 2013 Accepted: 03 January 2014 in Treatment of CNS Published: 06 January 2014 Copyright Hemangioblastomas in Patients © 2014 Gläsker et al. OPEN ACCESS with VHL Keywords • Hemangioblastoma Marie T. Krüger1, Jan-Helge Klingler1, Christine Steiert1, Cordula • von Hippel-Lindau disease Jilg2, Stefan Zschiedrich3, Birke Bausch4, Vera Van Velthoven1 and • Surgical treatment • Diagnosis; Follow-up Sven Gläsker1* 1Department of Neurosurgery, Freiburg University Medical Center, Germany 2Department of Urology, Freiburg University Medical Center, Germany 3Department of Internal Medicine, Freiburg University Medical Center, Germany 42nd Department of Internal Medicine, Freiburg University Medical Center, Germany Abstract Hemangioblastomas are a rare form of benign vascular tumors of the CNS. They can occur sporadically or as component of the von Hippel-Lindau (VHL) disease - an autosomal dominant tumor syndrome. The tumors are typically located in the posterior fossa and spinal cord. Patients with associated VHL disease are usually affected at an early age and develop multiple lesions. Therefore they need a special routine for diagnosis, treatment and follow-up strategies. In modern neurosurgery, hemangioblastomas are well resectable tumors. Symptomatic lesions should be removed. Resection should furthermore be considered for asymptomatic progressive tumors for the following reason: If a tumor has already caused neurological deficits, the chance to reverse these by surgical resection is reduced and surgical resection is usually possible with low morbidity. -
Charts Chart 1: Benign and Borderline Intracranial and CNS Tumors Chart
Charts Chart 1: Benign and Borderline Intracranial and CNS Tumors Chart Glial Tumor Neuronal and Neuronal‐ Ependymomas glial Neoplasms Subependymoma Subependymal Giant (9383/1) Cell Astrocytoma(9384/1) Myyppxopapillar y Desmoplastic Infantile Ependymoma Astrocytoma (9412/1) (9394/1) Chart 1: Benign and Borderline Intracranial and CNS Tumors Chart Glial Tumor Neuronal and Neuronal‐ Ependymomas glial Neoplasms Subependymoma Subependymal Giant (9383/1) Cell Astrocytoma(9384/1) Myyppxopapillar y Desmoplastic Infantile Ependymoma Astrocytoma (9412/1) (9394/1) Use this chart to code histology. The tree is arranged Chart Instructions: Neuroepithelial in descending order. Each branch is a histology group, starting at the top (9503) with the least specific terms and descending into more specific terms. Ependymal Embryonal Pineal Choro id plexus Neuronal and mixed Neuroblastic Glial Oligodendroglial tumors tumors tumors tumors neuronal-glial tumors tumors tumors tumors Pineoblastoma Ependymoma, Choroid plexus Olfactory neuroblastoma Oligodendroglioma NOS (9391) (9362) carcinoma Ganglioglioma, anaplastic (9522) NOS (9450) Oligodendroglioma (9390) (9505 Olfactory neurocytoma Ganglioglioma, malignant (()9521) anaplastic (()9451) Anasplastic ependymoma (9505) Olfactory neuroepithlioma Oligodendroblastoma (9392) (9523) (9460) Papillary ependymoma (9393) Glioma, NOS (9380) Supratentorial primitive Atypical EdEpendymo bltblastoma MdllMedulloep ithliithelioma Medulloblastoma neuroectodermal tumor tetratoid/rhabdoid (9392) (9501) (9470) (PNET) (9473) tumor -
Central Nervous System Tumors General ~1% of Tumors in Adults, but ~25% of Malignancies in Children (Only 2Nd to Leukemia)
Last updated: 3/4/2021 Prepared by Kurt Schaberg Central Nervous System Tumors General ~1% of tumors in adults, but ~25% of malignancies in children (only 2nd to leukemia). Significant increase in incidence in primary brain tumors in elderly. Metastases to the brain far outnumber primary CNS tumors→ multiple cerebral tumors. One can develop a very good DDX by just location, age, and imaging. Differential Diagnosis by clinical information: Location Pediatric/Young Adult Older Adult Cerebral/ Ganglioglioma, DNET, PXA, Glioblastoma Multiforme (GBM) Supratentorial Ependymoma, AT/RT Infiltrating Astrocytoma (grades II-III), CNS Embryonal Neoplasms Oligodendroglioma, Metastases, Lymphoma, Infection Cerebellar/ PA, Medulloblastoma, Ependymoma, Metastases, Hemangioblastoma, Infratentorial/ Choroid plexus papilloma, AT/RT Choroid plexus papilloma, Subependymoma Fourth ventricle Brainstem PA, DMG Astrocytoma, Glioblastoma, DMG, Metastases Spinal cord Ependymoma, PA, DMG, MPE, Drop Ependymoma, Astrocytoma, DMG, MPE (filum), (intramedullary) metastases Paraganglioma (filum), Spinal cord Meningioma, Schwannoma, Schwannoma, Meningioma, (extramedullary) Metastases, Melanocytoma/melanoma Melanocytoma/melanoma, MPNST Spinal cord Bone tumor, Meningioma, Abscess, Herniated disk, Lymphoma, Abscess, (extradural) Vascular malformation, Metastases, Extra-axial/Dural/ Leukemia/lymphoma, Ewing Sarcoma, Meningioma, SFT, Metastases, Lymphoma, Leptomeningeal Rhabdomyosarcoma, Disseminated medulloblastoma, DLGNT, Sellar/infundibular Pituitary adenoma, Pituitary adenoma, -
Seizure Prognosis of Patients with Low-Grade Tumors
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Seizure 21 (2012) 540–545 Contents lists available at SciVerse ScienceDirect Seizure jou rnal homepage: www.elsevier.com/locate/yseiz Seizure prognosis of patients with low-grade tumors a b,c c,d c,e Cynthia A. Kahlenberg , Camilo E. Fadul , David W. Roberts , Vijay M. Thadani , c,e a,f c,e, Krzysztof A. Bujarski , Rod C. Scott , Barbara C. Jobst * a Dartmouth College, Hanover, NH, United States b Sections of Hematology, Oncology and Neurology, Dartmouth Hitchcock Medical Center, Lebanon, NH, United States c Dartmouth Medical School, Hanover, NH, United States d Section of Neurosurgery, Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH, United States e Department of Neurology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, United States f Neurosciences Unit, Institute of Child Health, University College London, Great Ormond Street Hospital for Children NHS Trust, London, UK A R T I C L E I N F O A B S T R A C T Article history: Purpose: Seizures frequently impact the quality of life of patients with low grade tumors. Management is Received 12 January 2012 often based on best clinical judgment. We examined factors that correlate with seizure outcome to Received in revised form 24 May 2012 optimize seizure management. Accepted 24 May 2012 Methods: Patients with supratentorial low-grade tumors evaluated at a single institution were retrospectively reviewed. Using multiple regression analysis the patient characteristics and treatments Keywords: were correlated with seizure outcome using Engel’s classification. -
Choroid Plexus Papilloma Arising from the Temporal Horn with a Bilateral Hypersecretory Hydrocephalus: a Case Report and Review of Literature
Elmer ress Case Report World J Oncol. 2016;7(2-3):51-56 Choroid Plexus Papilloma Arising From the Temporal Horn With a Bilateral Hypersecretory Hydrocephalus: A Case Report and Review of Literature Sureswar Mohantya, Suman Saurav Routb, d, Gouri Sankar Sarangia, Kumudini Devic Abstract occur in the third ventricle. These tumors are benign histologi- cally and are neuroectodermal in origin and assigned a WHO Cerebrospinal fluid (CSF) within the cerebral ventricular system is grade I. Complete or gross total resection of these tumors often secreted by a neuroepithelial tissue which is called as the choroid results in a cure and almost recurrence free survival. The spe- plexus. Tumors arising from these tissues are rare. Choroid plexus cial challenges in the management of these tumors are mostly papillomas (CPPs) have been denoted as WHO grade I of the cho- due to its several unique features which include the young age roid plexus tumors. Among the intracranial tumors, neoplasms of the at presentation, high vascularity of these tumors and the poten- choroid plexus constitute around 0.36-0.6%. CPPs are mostly slow tial for hypersecretion of CSF. growing and cause symptoms due to mass effect and obstructive hy- drocephalus, resulting in increased intracranial pressure. We report a Case Report case of CPP arising from the temporal horn in a 7-year-old girl pre- senting with progressive head enlargement since birth due to bilateral massive hydrocephalus without any obstruction, making it purely a A 7-year-old girl presented with progressive head enlargement hypersecretory hydrocephalus. A drainage procedure followed by since birth, features of raised intracranial pressure in the form complete tumor resection was carried out in our case and the patient of headache, vomiting, excessive crying and excessive drowsi- showed marked relief from her symptoms. -
Telovelar Approach to the Fourth Ventricle: Microsurgical Anatomy
J Neurosurg 92:812–823, 2000 Telovelar approach to the fourth ventricle: microsurgical anatomy ANTONIO C. M. MUSSI, M.D., AND ALBERT L. RHOTON, JR., M.D. Department of Neurological Surgery, University of Florida, Gainesville, Florida Object. In the past, access to the fourth ventricle was obtained by splitting the vermis or removing part of the cere- bellum. The purpose of this study was to examine the access to the fourth ventricle achieved by opening the tela cho- roidea and inferior medullary velum, the two thin sheets of tissue that form the lower half of the roof of the fourth ven- tricle, without incising or removing part of the cerebellum. Methods. Fifty formalin-fixed specimens, in which the arteries were perfused with red silicone and the veins with blue silicone, provided the material for this study. The dissections were performed in a stepwise manner to simulate the exposure that can be obtained by retracting the cerebellar tonsils and opening the tela choroidea and inferior medullary velum. Conclusions. Gently displacing the tonsils laterally exposes both the tela choroidea and the inferior medullary velum. Opening the tela provides access to the floor and body of the ventricle from the aqueduct to the obex. The additional opening of the velum provides access to the superior half of the roof of the ventricle, the fastigium, and the superolater- al recess. Elevating the tonsillar surface away from the posterolateral medulla exposes the tela, which covers the later- al recess, and opening this tela exposes the structure forming -
Stereotactic Radiosurgery in Hemangioblastoma
Published online: 2019-09-25 Original Article Stereotactic radiosurgery in hemangioblastoma: Experience over 14 years Nishant Goyal, Deepak Agrawal, Raghav Singla, Shashank Sharad Kale, Manmohan Singh, Bhawani Shankar Sharma Department of Neurosurgery and Gamma Knife, All India Institute of Medical Sciences, New Delhi, India ABSTRACT Background: Although gamma knife has been advocated for hemangioblastomas, it is not used widely by neurosurgeons. Objective: We review our experience over 14 years in an attempt to define the role of stereotactic radiosurgery (SRS) in the management of hemangioblastomas. Patients and Methods: A retrospective study was conducted on all patients of hemangioblastoma who underwent SRS at our institute over a period of 14 years (1998–2011). Gamma knife plans, clinical history, and radiology were reviewed for all patients. Results: A total of 2767 patients underwent gamma knife during the study period. Of these, 10 (0.36%) patients were treated for 24 hemangioblastomas. Eight patients (80%) had von Hippel‑Lindau disease while two had sporadic hemangioblastomas. The median peripheral dose (50% isodose) delivered to the tumors was 29.9 Gy. Clinical and radiological follow‑up data were available for eight patients. Of these, two were re‑operated for persisting cerebellar symptoms. The remaining six patients were recurrence‑free at a mean follow‑up of 48 months (range 19–108 months). One patient had an increase in cyst volume along with a decrease in the size of the mural nodule. Conclusions: SRS should be the first option for asymptomatic hemangioblastomas. Despite the obvious advantages, gamma knife is not widely used as an option for hemangioblastomas. Key words: Gamma knife radiosurgery, hemangioblastomas, stereotactic radiosurgery, von Hippel‑Lindau syndrome Introduction view of site, vascularity, and number. -
Neuroendoscopic Choroid Plexus Coagulation for Pediatric Hydrocephalus
32 Review Neuroendoscopic Choroid Plexus Coagulation for Pediatric Hydrocephalus: Review of Historical Aspects and Rebirth Coagulação Neuroendoscópica do Plexo Coróide: Revisão de Aspectos Históricos e Renascimento Roberto Alexandre Dezena1 Carlos Umberto Pereira2 Leopoldo Prézia de Araújo1 Monique Passos Ribeiro3 Helisângela Alves de Oliveira3 ABSTRACT This study aims to review historical aspects and rebirth of the neuroendoscopic choroid plexus coagulation (NCPC) for pediatric hydrocephalus. The literature covering this topic in PubMed was reviewed. The first NCPC procedure goes back to early 1930s. After the development of other treatment methods and the understanding of CSF dynamics, the application of NCPC dramatically decreased by 1970s. In 2000s, there was a rebirth of NCPC in combination with endoscopic third ventriculostomy (ETV). NCPC remains one of the options for the treatment of pediatric hydrocephalus in selected cases. NCPC might provide a temporary reduction in CSF production to allow a further development of CSF absorption in infant. Adding NCPC to ETV for infants with communicating hydrocephalus may increase the shunt independent rate thus avoiding the consequence of late complication related to the shunt device. This is important for patients who are difficult to be followed up, due to geographical and/or socioeconomic difficulties. Besides, adding NCPC to ETV for obstructive hydrocephalus in infant may also increase the successful rate. Furthermore, NCPC may be an option for cases with high chance of shunt complication such as multiloculated hydrocephalus, extreme hydrocephalus and hydranencephaly. In comparison with the traditional treatment of CSF shunting, the role of NCPC needs to be further evaluated in particular concerning the neurocognitive development. Key words: Pediatric hydrocephalus; Neuroendoscopic choroid plexus coagulation; Endoscopic third ventriculostomy. -
Clinical, Radiological, and Pathological Features in 43 Cases of Intracranial Subependymoma
CLINICAL ARTICLE J Neurosurg 122:49–60, 2015 Clinical, radiological, and pathological features in 43 cases of intracranial subependymoma Zhiyong Bi, MD, Xiaohui Ren, MD, Junting Zhang, MD, and Wang Jia, MD Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China ObjECT Intracranial subependymomas are rarely reported due to their extremely low incidence. Knowledge about sub- ependymomas is therefore poor. This study aimed to analyze the incidence and clinical, radiological, and pathological features of intracranial subependymomas. METHodS Approximately 60,000 intracranial tumors were surgically treated at Beijing Tiantan Hospital between 2003 and 2013. The authors identified all cases in which patients underwent resection of an intracranial tumor that was found to be pathological examination demonstrated to be subependymoma and analyzed the data from these cases. RESULTS Forty-three cases of pathologically confirmed, surgically treated intracranial subependymoma were identi- fied. Thus in this patient population, subependymomas accounted for approximately 0.07% of intracranial tumors (43 of an estimated 60,000). Radiologically, 79.1% (34/43) of intracranial subependymomas were misdiagnosed as other dis- eases. Pathologically, 34 were confirmed as pure subependymomas, 8 were mixed with ependymoma, and 1 was mixed with astrocytoma. Thirty-five patients were followed up for 3.0 to 120 months after surgery. Three of these patients expe- rienced tumor recurrence, and one died of tumor recurrence. Univariate analysis revealed that shorter progression-free survival (PFS) was significantly associated with poorly defined borders. The association between shorter PFS and age < 14 years was almost significant (p = 0.51), and this variable was also included in the multivariate analysis. -
Disseminated Hemangioblastoma of the Central Nervous System Without Von Hippel-Lindau Disease
Brain Tumor Res Treat 2014;2(2):96-101 / pISSN 2288-2405 / eISSN 2288-2413 CASE REPORT http://dx.doi.org/10.14791/btrt.2014.2.2.96 Disseminated Hemangioblastoma of the Central Nervous System without Von Hippel-Lindau Disease Sun-Yoon Chung, Sin-Soo Jeun, Jae-Hyun Park Department of Neurosurgery, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea Hemangioblastoma (HB) of the central nervous system may occur sporadically or in association with von Hippel-Lindau (VHL) disease. Disseminated HB means malignant spread of the original primary HB without local recurrence at surgically resected site. It has been rarely reported previously, and rarer especially without VHL gene mutation. We report a case of disseminated HB without VHL disease. A Received June 19, 2014 59-year-old man underwent a surgery for total removal of a cerebellar HB. From five years after the Revised July 8, 2014 surgery, multiple dissemination of HB was identified intracranially and he subsequently underwent cy- Accepted August 7, 2014 berknife radiosurgery. The lesions got smaller temporarily, but they soon grew larger. Nine years after Correspondence the initial surgery for cerebellar HB, he showed severe back pain. His magnetic resonance image of Jae-Hyun Park spine revealed intradural extramedullary mass at T6–7 level. Complete surgical removal of the mass Department of Neurosurgery, was performed and the pathological diagnosis was identical to the previous one. He had no evidence Seoul St. Mary’s Hospital, of VHL disease. And there was no recurrence of the tumor at the site of the original operation.